Meningococcal disease is a rare but serious disease that can cause significant illness, disability and death. Meningococcal vaccination for certain groups of people is funded under the National Immunisation Program and by states and territories. No single vaccine protects against all serogroups. 3 vaccines protect against serogroups A, C, W and Y (MenACWY vaccines). 2 vaccines protect against serogroup B only (Men B vaccines). 2 vaccines protect against serogroup C only (MenC vaccine and Hib-MenC vaccine). The number of doses depends on the vaccine brand and the person’s age when they start the vaccination course. Aboriginal and Torres Strait Islander people aged 6 weeks to 19 years are recommended to receive Men B and MenACWY. Non-Indigenous people are recommended to receive MenB and MenACWY at age 6 weeks to 23 months, and at age 15–19 years. See the Australian Immunisation Handbook for more details abut recommended vaccines and doses in children aged 6 weeks to 23 months. Healthy children and adolescents do not need booster doses unless they fall into certain special risk groups. See the Australian Immunisation Handbook for more details.
These files may not be suitable for users of assistive technology. Request an accessible format.
Printed content may be out of date. For up to date information, always refer to the digital version: https://immunisationhandbook.health.gov.au/resources/publications/meningococcal-vaccination-for-children-and-adolescents-without-risk-factors.